All three recipients were awarded the prize for their research in cancer development and treatment. The Wolf Prize is recognized as being among the world's most prestigious prizes in science and the arts. The prizes will be awarded by Israeli President Moshe Katsav at a ceremony in May at the Knesset, Israel's parliament.
The other two prize winners in medicine are Prof. Anthony R. Hunter of the Salk Institute of La Jolla, CA, in the U.S. and Prof. Anthony J. Pawson of the Lunenfeld Research Institute at Mount Sinai Hospital in Toronto, Canada.
Prof. Levitzki, of the Department of Biological Chemistry at the Alexander Silberman Institute of Life Sciences at the Hebrew University, was specifically cited for his work in developing techniques for targeted destruction of cancer cells through biochemical means, without harming normal cells. His work has led to successful therapy in treating leukemia patients, the Wolf Prize jury noted.
Prof. Levitzki, aged 64, was born in Israel and received his Ph.D. in biochemistry and biophysics from the Hebrew University of Jerusalem and the Weizmann Institute of Science. He was appointed as associate professor at the Hebrew University in 1975 and a full professor the following year.
He has served in various positions at the university, including heading the Silberman Institute of Life Sciences, the Institute of Advanced Studies and the Wolfson Center for Applied Structural Biology. He is a member of the Israel Academy of Sciences and Humanities and has been a visiting scientist at the U.S. National Cancer Institute and a visiting scholar at Stanford University in California. He is the winner of the Israel Prize, Israel's highest civilian honour.
MEDICA.de; Source: Hebrew University of Jerusalem